American Portfolios Advisors Abbott Laboratories Transaction History

American Portfolios Advisors

$2.36 Trillion
Q3 2022

A detailed history of American Portfolios Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, American Portfolios Advisors holds 51,393 shares of ABT stock, worth $6.06 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

51,393

Holding current value

$6.06 Million

% of portfolio

0.21%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 17, 2023	BUY	$96.76 - $112.03 $4.97 Million - $5.76 Million	51,393 New	51,393 $4.97 Billion
Q2 2022 Mar 20, 2023	SELL	$102.07 - $123.37 $2.38 Million - $2.87 Million	-23,303 Reduced 45.34%	28,090 $3.05 Billion
Q1 2022 Mar 21, 2023	SELL	$114.02 - $139.04 $2.6 Million - $3.17 Million	-22,813 Reduced 44.39%	28,580 $3.38 Billion
Q4 2021 Mar 21, 2023	SELL	$115.53 - $141.46 $1.4 Million - $1.71 Million	-12,104 Reduced 23.55%	39,289 $5.53 Billion
Q3 2021 Mar 22, 2023	SELL	$116.66 - $129.06 $1.45 Million - $1.61 Million	-12,444 Reduced 24.21%	38,949 $4.6 Billion
Q2 2021 Mar 22, 2023	SELL	$105.79 - $124.53 $1.99 Million - $2.35 Million	-18,857 Reduced 36.69%	32,536 $3.77 Billion
Q1 2021 Mar 22, 2023	SELL	$108.84 - $128.23 $1.84 Million - $2.17 Million	-16,887 Reduced 32.86%	34,506 $4.14 Billion
Q4 2020 Mar 22, 2023	SELL	$105.0 - $114.42 $2.35 Million - $2.56 Million	-22,347 Reduced 43.48%	29,046 $3.18 Billion
Q3 2020 Mar 22, 2023	SELL	$91.64 - $111.29 $757,312 - $919,700	-8,264 Reduced 16.08%	43,129 $4.69 Billion
Q2 2020 Mar 24, 2023	BUY	$76.57 - $98.0 $107,197 - $137,200	1,400 Added 3.85%	37,717 $3.45 Billion
Q1 2020 Mar 24, 2023	SELL	$62.82 - $91.86 $947,074 - $1.38 Million	-15,076 Reduced 29.33%	36,317 $2.87 Billion
Q4 2019 Mar 24, 2023	SELL	$78.51 - $87.4 $1.92 Million - $2.14 Million	-24,496 Reduced 47.66%	26,897 $2.34 Billion
Q3 2019 Mar 24, 2023	BUY	$81.84 - $88.74 $118,422 - $128,406	1,447 Added 5.69%	26,872 $2.25 Billion
Q2 2019 Mar 24, 2023	SELL	$72.88 - $85.0 $1.89 Million - $2.21 Million	-25,968 Reduced 50.53%	25,425 $2.14 Billion
Q1 2019 Mar 24, 2023	BUY	$66.22 - $80.06 $706,964 - $854,720	10,676 Added 65.57%	26,958 $2.16 Billion
Q4 2018 Mar 24, 2023	BUY	$65.56 - $74.27 $41,565 - $47,087	634 Added 4.05%	16,282 $1.18 Billion
Q3 2018 Mar 24, 2023	SELL	$60.81 - $73.36 $2.17 Million - $2.62 Million	-35,745 Reduced 69.55%	15,648 $1.15 Billion
Q2 2018 Mar 24, 2023	BUY	$57.57 - $63.54 $34,599 - $38,187	601 Added 4.19%	14,936 $911 Million
Q1 2018 Mar 24, 2023	SELL	$56.27 - $63.62 $2.09 Million - $2.36 Million	-37,058 Reduced 72.11%	14,335 $859 Million
Q4 2017 Mar 24, 2023	SELL	$53.68 - $57.47 $2.05 Million - $2.19 Million	-38,165	13,228 $755 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Account

American Portfolios Advisors Abbott Laboratories Transaction History